Results

Kymera Therapeutics Inc.

07/12/2021 | Press release | Distributed by Public on 07/12/2021 06:03

Kymera Therapeutics Presents New Preclinical Data on STAT3 Degraders Showing Antitumor Activity in STAT3 Mutant and Wild-Type Peripheral T-Cell Lymphoma at 13th Annual T-Cell[...]